FORMULATION AND EVALUATION OF LEVODOPA EFFERVESCENT FLOATING TABLETS
Keywords:
Levodopa, Polyethylene oxide (PEO), Sodium bicarbonate, Floating drug delivery system, Effervescent floating tabletsAbstract
Objective: Levodopa is an immediate precursor of dopamine used in treatment of Parkinsonism disorders. The Levodopa effervescent floating tablets were prepared by direct compression technique, using different low density polymers (POLYOX different grades) in various drug polymer ratios.
Methods: The Levodopa effervescent floating tablets were prepared by direct compression method. The floating tablets were evaluated for friability, thickness, hardness, weight variation test, drug content, in vitro release and floating properties. The drug excipients compatability was evaluated by DSC and FT-IR study.
Results: All the batches showed compliance with pharmacopoeia standards. Among all the formulation F4 containing PEO WSR 303 in 1:1 drug polymer ratio showed controlled drug release for 12h (99.15%) emerging as the best formulation and follow first order kinetics via, swelling, diffusion. An in vitro buoyancy study reveals that all batches showed good in vitro buoyancy. The DSC study revealed that there was no strong interaction between Levodopa and excipients. Stability studies were carried out for best formulation F4 (PEO WSR 303 in 1:1 drug polymer ratio) according to ICH guidelines. Stability studies (40±2oC/75±5% RH) for 3 month indicated that Levodopa was stable in floating tablets.
Conclusion: Hence different grades of low density polymer (PEO) in various drug polymer ratios can be used to prepare Levodopa floating tablets for prolongation of gastric residence time with enhanced patient compliance.
Â
Downloads
References
Jaimini Manish, Patel Hardik. Gastro retentive floating drug delivery system: a review. IJPRBS 2013;2(2):358-77.
Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics a treatise. 1st ed. New Delhi: Vallabh Prakashan; 1995.
Garg R, Gupta GD. Progress in controlled gastroretentive delivery systems. Tropical J Pharm Res 2008;7(3):1055-66.
Singh BN, Kim HK. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Rel 2000;63:235-59.
AV Mayavanshi, SS Gajjar. Drug delivery systems to increase gastric retention of drugs: a review. Res J Pharm Tech 2008;1(4):345-8.
S Arora, J Ali, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. AAPS Pharm Sci Tech 2005;6(3):372-90.
Chawla G, Gupta P, Koradia V, Bansal AK. Gastroretention: A means to address regional variability in intestinal drug absorption. Pharm Tech 2003;27:250-68.
Lee J, Park J, Choi HJ. Development of oral drug delivery system using floating microspheres. Microencapsule 1999;16(6):715-29.
Deshpande, CT Rhodes, NH Shah, AW Malick. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm 1996;22:631–539.
Levodopa drug profile, The Merck Index-An Encyclopedia of Chemicals, Drugs, and Biologicals, Goodman & Gilman Las Bases Farmacologicas de la Terapeutica, 7 ed. Mexico, Ed. Panamericana; 1990. p. 466-72.
Remington the science and practice of pharmacy. 21st edition. Vol. 2; 2012. p. 1419-20.
Bhavana V, Khopade AJ, Jain WD, Shelly, Jain NK. Targeted oral drug delivery. Indian Drugs 1996;33:365-73.
Sellappan Velmurugan and P srinivas. Formulation and in vitro evaluation of Losartan potassium mucoadhesive buccal tablets. Asian J Pharm Clin Res 2013;6(3):125-30.
BYS katyayini, Velmurugan S, Nagarjuna reddy G. Formulation and evaluation of floating tablets of losartan potassium. Int J Pharm Pharm Sci 2013;5(3):559-65.
Patel VF, Patel NM, Yeole PG. Studies on formulation and evaluation ranitidine floating tablets. Ind J Pharm Sci 2005;67(6):703â€9.
Janez K, Jerneja O. A new amoxicillin/clavulanate therapeutic system-preparation, in vitro and pharmacokinetic evaluation. Int J Pharm 2007;335:106-13.
Shailesh TP, Laxmanbhai DP, Dasharath MP. Gastric floating matrix tablets, design and optimization using combination of polymers. Acta Pharm 2008;58:221-9.
Santosh giri, Sellappan velmurugan, sahithya chowdary. Formulation and evaluation of glipizide sustain release matrix tablets. Int J Pharm Pharm Sci 2013;5(1):354-60.
Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-9.
Shailesh TP, Laxmanbhai DP, Dasharath MP. Gastric floating matrix tablets, design and optimization using combination of polymers. Acta Pharm 2008;58:221-9.
Sellappan Velmurugan, kiran kumar. Formulation and in vitro evaluation of glipizide mucoadhesive buccal tablets. Int J Pharm Biol Sci 2013;4(2):594-607.
K Naga Raju, S Velmurugan, B Deepika, Sundar Vinushitha. Formulation and In-vitro evaluation of buccal tablets of metoprolol tartrate. Int J Pharm Pharm Sci 2011;3(2):239-46.
United state pharmacopeia XXX the upconuetion; 2007.
Johns, Bengamin Onnoonay. Hydrophilic polymer viscosities on gastro retentive drug delivery systems of Gabapentin sustained release tablets. TUI; 2010. p. 354.
R Jacky Dias, S Shamling Sakhare, K Krishnal Mail. Design and development of mucoadhesive acyclovir tablet. Int J Prod Res 2009;8(4):231-9.
Labot M, Ruben M, Allemandi D. Double-layered mucoadhesive tablets containing Nystatin. J AAPS Pharm Sci Technol 2002;3(3):22:1-6.